| 2021-10-22 | Sale | 4D Molecular Therapeutics, Inc. FDMT | director | 1,900 0.0067% | $31.00 | $58,893 | -62.15% | |
| 2021-10-21 | Sale | 4D Molecular Therapeutics, Inc. FDMT | director | 22,820 0.0844% | $31.56 | $720,156 | -60.69% | |
| 2021-10-20 | Sale | 4D Molecular Therapeutics, Inc. FDMT | director | 11,565 0.0433% | $31.02 | $358,771 | -59% | |
| 2021-09-30 | Sale | 4D Molecular Therapeutics, Inc. FDMT | director | 12,385 0.0457% | $26.91 | $333,250 | -49.31% | |
| 2021-09-29 | Sale | 4D Molecular Therapeutics, Inc. FDMT | director | 16,871 0.064% | $28.61 | $482,614 | -50.66% | |
| 2021-09-28 | Sale | 4D Molecular Therapeutics, Inc. FDMT | director | 13,912 0.0517% | $30.53 | $424,693 | -54.38% | |
| 2021-09-27 | Sale | 4D Molecular Therapeutics, Inc. FDMT | director | 19,332 0.073% | $32.89 | $635,826 | -56.94% | |
| 2020-01-28 | Sale | uniQure N.V. QURE | director | 1,612 0.0037% | $62.27 | $100,379 | -27.28% | |
| 2019-01-28 | Sale | uniQure N.V. QURE | director | 1,210 0.0032% | $31.31 | $37,885 | +82.93% | |
| 2019-01-17 | Sale | uniQure N.V. QURE | director | 7,500 0.0196% | $30.71 | $230,325 | +83.57% | |
| 2018-01-29 | Sale | uniQure N.V. QURE | director | 2,878 0.009% | $18.53 | $53,329 | +59.46% |